BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20222854)

  • 1. Natural products in structure-assisted design of molecular cancer therapeutics.
    Pfisterer PH; Wolber G; Efferth T; Rollinger JM; Stuppner H
    Curr Pharm Des; 2010 May; 16(15):1718-41. PubMed ID: 20222854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ready for a comeback of natural products in oncology.
    Bailly C
    Biochem Pharmacol; 2009 May; 77(9):1447-57. PubMed ID: 19161987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy.
    Franke J; Eichner S; Zeilinger C; Kirschning A
    Nat Prod Rep; 2013 Oct; 30(10):1299-323. PubMed ID: 23934201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current impact of natural products in the discovery of anticancer drugs].
    Monneret C
    Ann Pharm Fr; 2010 Jul; 68(4):218-32. PubMed ID: 20637355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of natural products derivatization method in the design of targeted anticancer agents from 2000 to 2018.
    Liu W; Li Q; Hu J; Wang H; Xu F; Bian Q
    Bioorg Med Chem; 2019 Dec; 27(23):115150. PubMed ID: 31635893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural product inhibitors of Hsp90: potential leads for drug discovery.
    Amolins MW; Blagg BS
    Mini Rev Med Chem; 2009 Feb; 9(2):140-52. PubMed ID: 19200020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent studies on natural products as anticancer agents.
    Ravelo AG; Estévez-Braun A; Chávez-Orellana H; Pérez-Sacau E; Mesa-Siverio D
    Curr Top Med Chem; 2004; 4(2):241-65. PubMed ID: 14754457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: current trends.
    Saha SK; Khuda-Bukhsh AR
    Eur J Pharmacol; 2013 Aug; 714(1-3):239-48. PubMed ID: 23819913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HSP90: a rising star on the horizon of anticancer targets.
    Dai C; Whitesell L
    Future Oncol; 2005 Aug; 1(4):529-40. PubMed ID: 16556029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoxazoline containing natural products as anticancer agents: a review.
    Kaur K; Kumar V; Sharma AK; Gupta GK
    Eur J Med Chem; 2014 Apr; 77():121-33. PubMed ID: 24631731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside?
    Khandelwal A; Crowley VM; Blagg BSJ
    Med Res Rev; 2016 Jan; 36(1):92-118. PubMed ID: 26010985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat Shock Proteins (HSPs): A Novel Target for Cancer Metastasis Prevention.
    Narayanankutty V; Narayanankutty A; Nair A
    Curr Drug Targets; 2019; 20(7):727-737. PubMed ID: 30526455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial; Natural Product Inhibitors of Enzymatic Targets in Anticancer Drug Discovery - Part II.
    Scotti L; Scotti MT
    Curr Protein Pept Sci; 2018 Feb; 19(4):342. PubMed ID: 29493446
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational approaches to natural-product-based drug design.
    Haustedt LO; Mang C; Siems K; Schiewe H
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):445-62. PubMed ID: 16889228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comprehensive Review of N-Heterocycles as Cytotoxic Agents.
    Kumar D; Jain SK
    Curr Med Chem; 2016; 23(38):4338-4394. PubMed ID: 27516198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective.
    Kumalo HM; Bhakat S; Soliman ME
    Chem Biol Drug Des; 2015 Nov; 86(5):1131-60. PubMed ID: 25958815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Product Kongensin A is a Non-Canonical HSP90 Inhibitor that Blocks RIP3-dependent Necroptosis.
    Li D; Li C; Li L; Chen S; Wang L; Li Q; Wang X; Lei X; Shen Z
    Cell Chem Biol; 2016 Feb; 23(2):257-266. PubMed ID: 27028885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purine-scaffold Hsp90 inhibitors.
    Chiosis G; Tao H
    IDrugs; 2006 Nov; 9(11):778-82. PubMed ID: 17096299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Simplification of Natural Products.
    Wang S; Dong G; Sheng C
    Chem Rev; 2019 Mar; 119(6):4180-4220. PubMed ID: 30730700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.